PART I Overview We are a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patients own anatomy. Our growing product portfolio is purposefully designed to leverage the patients natural healing response while minimizing long-term exposure to permanent synthetic materials. We are committed to delivering our advanced technologies with a strong econom...
Q2 FY2026 — expected 2026-08-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-25 | 2025-12-31 | 0001104659-26-034507 | EDGAR | 86K words |
| 2025-03-21 | 2024-12-31 | 0001558370-25-003460 | EDGAR | — |
| 2024-03-22 | 2023-12-31 | 0001558370-24-003782 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0001558370-23-004468 | EDGAR | — |
| 2022-03-23 | 2021-12-31 | 0001558370-22-004151 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001558370-21-003483 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001558370-20-003346 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001104659-26-094039 | EDGAR | — |
| 2025-11-14 | 2025-09-30 | 0001104659-25-112476 | EDGAR | 21K words |
| 2025-08-11 | 2025-06-30 | 0001558370-25-011052 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001558370-25-006994 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001558370-24-015050 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001558370-24-012060 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001558370-24-007784 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001558370-23-018822 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001558370-23-014494 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009426 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017464 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001558370-22-013286 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-10 | 0001104659-26-093371 | EDGAR | — |
| 2026-08-04 | 0001104659-26-090056 | EDGAR | — |
| 2026-03-24 | 0001104659-26-033839 | EDGAR | 3K words |
| 2026-03-20 | 0001104659-26-032697 | EDGAR | — |
| 2025-11-14 | 0001104659-25-112653 | EDGAR | — |
| 2025-11-13 | 0001104659-25-111285 | EDGAR | — |
| 2025-11-03 | 0001104659-25-105548 | EDGAR | — |
| 2025-10-09 | 0001104659-25-098354 | EDGAR | — |
| 2025-08-11 | 0001104659-25-076153 | EDGAR | — |
| 2025-06-02 | 0001104659-25-055248 | EDGAR | — |
132 total filings indexed. 103 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001561921 |
| Ticker | TELA |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Website | https://www.telabio.com |
| Listed | 2019-11-08 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TELA (~200 tokens, structured JSON with cryptographic provenance)